PSMA PET scan to find early prostate cancer spread
Part of Cancer, Kidney & urinary clinical trials.
This study uses a PSMA PET scan to look for early spread of prostate cancer in men with higher-risk genetic test results (Decipher score above 0.45). It may help doctors spot metastases sooner so treatment decisions can be better targeted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were previously enrolled in a related study called MCC#18523
- Your Decipher genetic test score was high (greater than 0.45)
- You completed Decipher/Genomic Classifier testing from a biopsy or surgery tissue sample
- Your prostate cancer was treated with surgery or radiation, with at least 2 years of follow-up
- Your overall health is good enough for study activities (ECOG 0–1)
- You can safely have a PET scan (not limited by severe claustrophobia or other issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial will test if a special PET scan (18F-DCFPyL) can help doctors plan your treatment with a radioactive medicine called 177Lu-vipivotide tetraxetan. You are eligible if you already qualify for that standard therapy and have had a prior PSMA PET scan showing at least one active cancer site.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
This trial tests whether a special PET scan (called PSMA, which pictures prostate cancer cells) can help doctors better find any remaining or spread of prostate cancer when your PSA level is rising again. It's for people who are planning radiation therapy, and the goal is to see if the scan changes the treatment plan.
This study tests whether a special PET scan (PSMA PET) can better detect prostate cancer in men whose MRI results are unclear. If it works, it may help avoid unnecessary biopsies or find cancer sooner.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.